How Long Is Compounded Semaglutide Good For? Beyond-Use Dates and Storage

Compounded medications are not dated the way mass-manufactured ones are. Yours carries a beyond-use date set by the pharmacy that prepared it, and storage is what keeps that date meaningful. Here is what the date means, where to find it, and what to do when a vial has been left out or the date has passed.

Majesta Health Editorial TeamReviewed by Majesta team
Published Updated 7 min read

Almost nobody asks this question casually. It comes up when a vial has been sitting on a counter for an afternoon, when a refill is late, or when someone opens the fridge and notices a date they do not recognise. The answer starts with the fact that compounded medications are not dated the way mass-manufactured ones are.

Quick Answer

As of September 26, 2026, compounded semaglutide carries a beyond-use date, not a manufacturer expiration date. The pharmacy that prepared it sets that date for that preparation, based on the formulation, the container, and how it is stored, and prints it on the label. It is typically much shorter than the date on a mass-manufactured product. Follow the label, with one federal caution that sits above it: for a vial containing multiple doses of a sterile compounded medication, FDA recommends: "Discard the vial within 28 days after the first use, even if medication remains in the vial," and it adds that this holds even if the compounder's instructions say the medication can be used for longer; the FDA also says not to use any injectable GLP-1 medication that arrives warm or without enough refrigeration. Compounded medications are not FDA-approved as final products.

Beyond-Use Date, Not an Expiration Date

The two terms get used interchangeably in conversation, and they are not the same thing.

An expiration date belongs to a mass-manufactured product. The manufacturer runs a stability programme on that exact formulation in that exact container, watching it over time under controlled conditions, and the date on the box is the conclusion of that work.

A beyond-use date belongs to a preparation compounded for an individual patient. There is no manufacturer stability programme behind a preparation made for one person, so the pharmacy assigns the date under United States Pharmacopeia standards, working from the formulation, the container it is dispensed in, and the storage conditions it is expected to see. The result is deliberately conservative, and for compounded injectables it is far shorter than the years you see on a mass-manufactured product.

That conservatism is a feature. It is the pharmacy declining to guarantee something it has not tested, which is exactly what you would want from anyone preparing a medication for you.

Compounded medications are not FDA-approved as final products and have not been evaluated by the FDA for safety, effectiveness, or quality. The framework they are prepared under is Section 503A, which covers preparation against a prescription for a specific patient.

Where the Date Lives

On the pharmacy label, on the vial or its carton. That label is worth reading properly once, because it carries three things worth knowing before you need them:

  • the beyond-use date,
  • the storage instructions for that preparation,
  • the name and phone number of the pharmacy that prepared it.

If you have never taken a close look at a prescription label, our guide to what each line on the label means walks through it. If the label is missing, damaged, or has separated from the container, that is a reason to call the pharmacy rather than to estimate.

Storage Is What Keeps the Date Meaningful

A beyond-use date assumes the medication was kept the way the label says. Storage and dating are one subject, not two.

Refrigeration. Semaglutide products are generally stored refrigerated, commonly in the range of 36 to 46 degrees Fahrenheit, until they are in use. Your label states the range that applies to your preparation.

Room temperature. Some products allow a limited period at room temperature once in use. That allowance varies by product, and for a compounded preparation it is whatever the pharmacy has set for that preparation. The label, not a general article, is the authority for that allowance, and a longer label period does not set aside FDA's separate recommendation for a multidose vial after first use, quoted in the quick answer above.

Freezing. Product labeling for semaglutide products directs patients not to freeze them and not to use a product that has been frozen. A vial pushed to the back of a fridge, against the cooling plate, is the usual way this happens by accident.

Light and handling. Keep the medication in its original carton when you are not using it, and out of direct sunlight and hot cars. Traveling has its own rules, which we cover in traveling with semaglutide or tirzepatide.

When Something Has Gone Wrong

The instinct is to look at the vial and judge. That instinct is the problem: a preparation stored outside its conditions can look completely normal, and a harmless bubble can look alarming. Appearance is not a test.

What to do instead, in every one of these cases, is the same. Note what happened, then call the pharmacy named on your label and ask. They set the conditions for that preparation and they are the only party holding the information the answer depends on.

What happenedWhat to do
Left out of the fridgeNote how long and roughly how warm, then call the pharmacy
Frozen, or suspected frozenDo not use it; call the pharmacy
Past the beyond-use dateCall the pharmacy, and speak with your prescriber about a refill
Multidose vial past the FDA limit after first use quoted above, even if the label date is laterDo not keep using it; call the pharmacy and your prescriber
Looks cloudy, discoloured, or has particlesDo not use it; call the pharmacy
Label missing or unreadableCall the pharmacy before using it

None of these is a reason to feel foolish. Refrigerators fail, bags get left in cars, and labels come off. The pharmacies that prepare these medications field these calls routinely.

Why the Dates Differ So Much From a Brand-Name Product

Patients often notice that a compounded preparation carries a much nearer date and read it as a sign of lower quality. It is a sign of a different framework.

A mass-manufactured product is one formulation, made in enormous quantities, in one container, tested for years. Everything about that setup supports a long dated shelf life. A compounded preparation is made for one patient against one prescription, and the dating standards for that work are built to be cautious in the absence of a product-specific stability programme.

Compounded medications are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication, and they are not dated by the same process either.

What To Ask Your Pharmacy

If you want to be ready before anything goes wrong, these four questions cover most of it:

  1. What is the beyond-use date on this preparation, what does it assume about storage, and how does it fit with FDA's separate limit after the vial is first used?
  2. What temperature range should I keep it in, and is there a room-temperature allowance once I start using it?
  3. How long can it be out of the fridge before I need to call you?
  4. What should I do if a shipment arrives warm?

The pharmacy that prepared your medication is named on the label. That is who to ask, and asking early is easier than asking with a vial in your hand and a dose due.

Anything about your treatment itself, including whether to continue, pause, or replace a dose, is a decision for the physician who prescribed it.

What the primary sources say

  • U.S. Food and Drug Administration, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (accessed September 29, 2026): "Discard the vial within 28 days after the first use, even if medication remains in the vial. Do not continue using medication from the vial after 28 days, even if instructions from the compounder say the medication can be used for longer than 28 days."
  • Code of Federal Regulations via Legal Information Institute, Cornell Law School, 21 CFR § 211.137 Expiration dating (accessed September 26, 2026): "To assure that a drug product meets applicable standards of identity, strength, quality, and purity at the time of use, it shall bear an expiration date determined by appropriate stability testing"
  • California State Board of Pharmacy regulation via Legal Information Institute, Cornell Law School, Cal. Code Regs. Tit. 16, § 1735.2 (accessed September 26, 2026): "Every compounded drug preparation shall be given a beyond use date representing the date or date and time beyond which the compounded drug preparation should not be used, stored, transported or administered, and determined based on the professional judgment of the pharmacist performing or supervising the compounding."
  • DailyMed, U.S. National Library of Medicine, WEGOVY (semaglutide) prescribing information, storage (accessed September 26, 2026): "Do not freeze WEGOVY and do not use WEGOVY if it has been frozen."
  • U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers (accessed September 26, 2026): "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."

Frequently Asked Questions

How long is compounded semaglutide good for?

The pharmacy assigns a beyond-use date to the specific preparation and prints its storage directions on the label. That date is separate from a limit after the vial is first used. Check both before using the medicine. For a multidose vial containing sterile compounded GLP-1 medication, FDA recommends: "Discard the vial within 28 days after the first use, even if medication remains in the vial." FDA says this recommendation still applies when the compounder gives a longer use period. Check the pharmacy's labeled beyond-use date and storage directions as well; the FDA recommendation does not extend an earlier limit. Ask your pharmacist or prescriber if dates or instructions conflict.

What is a beyond-use date and how is it different from an expiration date?

An expiration date belongs to a mass-manufactured product and comes from the manufacturer's own stability testing of that exact product in that exact container. A beyond-use date belongs to a preparation compounded for an individual patient, and the pharmacy assigns it under United States Pharmacopeia standards using the formulation, the container, and the storage conditions. Because a compounded preparation has not been through a manufacturer's stability programme, the date it carries is deliberately more conservative.

Where do I find the date on my medication?

On the pharmacy label attached to the vial or its carton. The label also names the pharmacy that prepared it, which is who to call with any question about the date or the storage instructions. If the label is missing, unreadable, or has come away from the container, treat that as a reason to call the pharmacy rather than to estimate.

What should I do if my semaglutide was left out of the fridge?

Do not decide by looking at it. Note how long it was out and at roughly what temperature, then call the pharmacy named on the label and ask. They set the storage conditions for that preparation and are the only party who can tell you whether it is still within them. Appearance is not a reliable test: a preparation can look completely normal and still have been stored outside its conditions.

Can I use compounded semaglutide after the beyond-use date?

That is a question for the pharmacy and your prescriber, not one to settle at home. The beyond-use date is the point past which the pharmacy is no longer standing behind the preparation, and using a medication past it is a decision made without the information the date was built on. Call the pharmacy on the label, and speak with your prescriber about a refill.

Does freezing ruin semaglutide?

Product labeling for semaglutide products directs patients not to freeze them and not to use a product that has been frozen. If a vial has frozen, or you suspect it has, do not use it and call the pharmacy named on your label.

Sources

This article is based on the following primary sources. Links open the original documents.

  1. 1.21 U.S. Code § 353a - Pharmacy compounding · Legal Information Institute, Cornell Law School (federal statute) · accessed
  2. 2.Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration · accessed
  3. 3.Cal. Code Regs. Tit. 16, § 1735.2 - Compounding Limitations and Requirements; Self-Assessment · California State Board of Pharmacy regulation, hosted by Legal Information Institute, Cornell Law School · accessed
  4. 4.Cal. Code Regs. Tit. 16, § 1751.8 - Beyond Use Dating for Sterile Compounded Drug Preparations · California State Board of Pharmacy regulation, hosted by Legal Information Institute, Cornell Law School · accessed
  5. 5.DailyMed - OZEMPIC- semaglutide injection, solution · DailyMed, U.S. National Library of Medicine (FDA-approved prescribing information) · accessed
  6. 6.DailyMed - WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet · DailyMed, U.S. National Library of Medicine (FDA-approved prescribing information) · accessed
  7. 7.21 CFR § 211.137 - Expiration dating · Legal Information Institute, Cornell Law School (Code of Federal Regulations) · accessed
  8. 8.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (vials containing multiple doses and storage during shipping) (content current as of 09/01/2026) · U.S. Food and Drug Administration · accessed

Telehealth prescribing rules differ by state. Read the state-by-state guide.

Reviewed by Majesta team

Majesta Health Editorial Team

Clinical Editorial Team

Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.

How this article was prepared
  • Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
  • Documented compliance review against FDA, FTC and LegitScript requirements before publication
  • External sources, where an article cites them, are listed at the end of that article with links to the original documents
  • Compounded medications are described as not FDA-approved as final products on every page that mentions them
Have a question for our medical team? See our full clinical team page or contact support.